Why is "Estradiol/drospirenone" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-25 06:28:09
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Estradiol/drospirenone entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-25 and was most recently seen on 2026-05-25.
Wikipedia Overview
Estradiol/drospirenone (E2/DRSP), sold under the brand name Angeliq, is a combination of estradiol (E2), an estrogen, and drospirenone (DRSP), a progestin, antimineralocorticoid, and antiandrogen, which is used in menopausal hormone therapy, specifically the treatment of menopausal syndrome and osteoporosis, in postmenopausal women. It is taken by mouth and contains 0.5 to 1 mg E2 and 0.25 to 0.5 mg DRSP per tablet. The medication was approved in the United States in 2005. It is marketed widely throughout the world.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
launches generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg - Lupin | Press Release - lupin.com
-
Oral contraceptives containing ethinyl estradiol and drospirenone increase hydroxylation and methylation of endogenous estrogen but not genotoxic estrogen DNA-adduct formation | Scientific Reports - nature.com
-
receives FDA approval for generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg - Lupin | Press Release - lupin.com
-
Drospirenone and Ethinyl Estradiol birth control pills recalled over packaging error - ABC11 News
-
Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression - frontiersin.org
-
Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 blister pack/carton due to possibility of missing/incorrect tablet arrangement - PR Newswire
-
Jubilant recalls one lot of Drospirenone and Ethinyl Estradiol tablets - Pharmaceutical Business review -
-
Mylan Launches Generic For Oral Contraceptive Yaz - drugdiscoverytrends.com
-
A randomized single-blind non-inferiority trial of delayed start with drospirenone-only and ethinyl estradiol-gestodene pills for ovulation inhibition - nature.com
-
Hormone replacement therapy (HRT) with drospirenone offers the additional benefit of blood pressure reduction in postmenopausal women - Springer Nature Link
-
Update on Current Contraceptive Options - Cleveland Clinic
-
Anti-Androgen therapy may increase UTI risk in women - Urology Times
-
Other Low-Dose Estrogen Combined Hormonal Contraceptive Formulations - Contemporary OB/GYN
-
Birth control pill recall announced by FDA - WBTV
-
Study Shows Elevated Risk of Blood Clots and Arterial Blockage in Women Taking Birth Control Pills Containing Drospirenone - divisionofresearch.kaiserpermanente.org
-
Birth control tablet packs recalled due to incorrect arrangement - WMAR 2 News Baltimore
-
A detailed review of pharmacokinetics/pharmacodynamics of progestogens in oral contraception - frontiersin.org
-
Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of TydemyTM (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Tablets 0.451mg) due to out of specification (OOS) re - PR Newswire
-
Birth control medication recalled over incorrect packaging - kvue.com
-
Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception - NEJM
-
Hormone therapy safe for women, study finds - Medical Xpress
-
Journavx interactions: Other drugs, alcohol, and more - Medical News Today
-
Hypertension in women - Hypertension Research - nature.com
-
Zepbound Interactions: Other Medications, Alcohol, and More - Healthline
-
Why The Pill May Impair Sleep - Medical Professionals Reference
-
Oral Contraceptive Recalled Due to Possibility of Reduced Efficacy - Medical Professionals Reference
-
FDA recalls birth control due to packaging issue - WBMA
-
Birth Control Pills Recalled Because Women Could Be Taking Placebos and Possibly Get Pregnant - People.com
-
Mirena: Side effects, uses, alternatives, and more - Medical News Today
-
Some Birth Control Pills Pose Gallstone Risk - MedPage Today
-
FDA wants blood clot risks added to Yaz labels - cbsnews.com
-
Apotex recalls tablets in US due to packaging error - Packaging Gateway
-
Daewon Pharm signs exclusive distribution deal with Bayer Korea for 2 hormone replacement therapies - Korea Biomedical Review
-
Birth Control Pills Recalled Nationwide Due To Packaging Error - Patch
-
Yaz Lawsuits - drugwatch.com
-
Camber launches generic Yaz - Drug Store News
-
Birth control sales continue despite drospirenone side effects - LawyersandSettlements.com
-
Teva releases Rajani birth control pill - Chain Drug Review
-
Birth Control recall announced due to faulty packaging - 95.3 MNC
-
Germany's Bayer faces shortage of contraceptive pill Yasmin in India - ET HealthWorld
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.